Cargando…

Pre-operative immunotherapy with tumor cryoablation (cryo) plus ipilimumab (ipi) induces potentially favorable systemic and intratumoral immune effects in early stage breast cancer (ESBC) patients

Detalles Bibliográficos
Autores principales: Page, David B, Diab, Adi, Yuan, Jianda, Dong, Zhiwan, Soloman, Stephen B, Patil, Sujata, Hudis, Clifford A, Wolchok, Jedd D, Norton, Larry, McArthur, Heather L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4547170/
http://dx.doi.org/10.1186/2051-1426-3-S1-O6
_version_ 1782387050192830464
author Page, David B
Diab, Adi
Yuan, Jianda
Dong, Zhiwan
Soloman, Stephen B
Patil, Sujata
Hudis, Clifford A
Wolchok, Jedd D
Norton, Larry
McArthur, Heather L
author_facet Page, David B
Diab, Adi
Yuan, Jianda
Dong, Zhiwan
Soloman, Stephen B
Patil, Sujata
Hudis, Clifford A
Wolchok, Jedd D
Norton, Larry
McArthur, Heather L
author_sort Page, David B
collection PubMed
description
format Online
Article
Text
id pubmed-4547170
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-45471702015-09-10 Pre-operative immunotherapy with tumor cryoablation (cryo) plus ipilimumab (ipi) induces potentially favorable systemic and intratumoral immune effects in early stage breast cancer (ESBC) patients Page, David B Diab, Adi Yuan, Jianda Dong, Zhiwan Soloman, Stephen B Patil, Sujata Hudis, Clifford A Wolchok, Jedd D Norton, Larry McArthur, Heather L J Immunother Cancer Oral Presentation BioMed Central 2015-08-14 /pmc/articles/PMC4547170/ http://dx.doi.org/10.1186/2051-1426-3-S1-O6 Text en Copyright © 2015 Page et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Oral Presentation
Page, David B
Diab, Adi
Yuan, Jianda
Dong, Zhiwan
Soloman, Stephen B
Patil, Sujata
Hudis, Clifford A
Wolchok, Jedd D
Norton, Larry
McArthur, Heather L
Pre-operative immunotherapy with tumor cryoablation (cryo) plus ipilimumab (ipi) induces potentially favorable systemic and intratumoral immune effects in early stage breast cancer (ESBC) patients
title Pre-operative immunotherapy with tumor cryoablation (cryo) plus ipilimumab (ipi) induces potentially favorable systemic and intratumoral immune effects in early stage breast cancer (ESBC) patients
title_full Pre-operative immunotherapy with tumor cryoablation (cryo) plus ipilimumab (ipi) induces potentially favorable systemic and intratumoral immune effects in early stage breast cancer (ESBC) patients
title_fullStr Pre-operative immunotherapy with tumor cryoablation (cryo) plus ipilimumab (ipi) induces potentially favorable systemic and intratumoral immune effects in early stage breast cancer (ESBC) patients
title_full_unstemmed Pre-operative immunotherapy with tumor cryoablation (cryo) plus ipilimumab (ipi) induces potentially favorable systemic and intratumoral immune effects in early stage breast cancer (ESBC) patients
title_short Pre-operative immunotherapy with tumor cryoablation (cryo) plus ipilimumab (ipi) induces potentially favorable systemic and intratumoral immune effects in early stage breast cancer (ESBC) patients
title_sort pre-operative immunotherapy with tumor cryoablation (cryo) plus ipilimumab (ipi) induces potentially favorable systemic and intratumoral immune effects in early stage breast cancer (esbc) patients
topic Oral Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4547170/
http://dx.doi.org/10.1186/2051-1426-3-S1-O6
work_keys_str_mv AT pagedavidb preoperativeimmunotherapywithtumorcryoablationcryoplusipilimumabipiinducespotentiallyfavorablesystemicandintratumoralimmuneeffectsinearlystagebreastcanceresbcpatients
AT diabadi preoperativeimmunotherapywithtumorcryoablationcryoplusipilimumabipiinducespotentiallyfavorablesystemicandintratumoralimmuneeffectsinearlystagebreastcanceresbcpatients
AT yuanjianda preoperativeimmunotherapywithtumorcryoablationcryoplusipilimumabipiinducespotentiallyfavorablesystemicandintratumoralimmuneeffectsinearlystagebreastcanceresbcpatients
AT dongzhiwan preoperativeimmunotherapywithtumorcryoablationcryoplusipilimumabipiinducespotentiallyfavorablesystemicandintratumoralimmuneeffectsinearlystagebreastcanceresbcpatients
AT solomanstephenb preoperativeimmunotherapywithtumorcryoablationcryoplusipilimumabipiinducespotentiallyfavorablesystemicandintratumoralimmuneeffectsinearlystagebreastcanceresbcpatients
AT patilsujata preoperativeimmunotherapywithtumorcryoablationcryoplusipilimumabipiinducespotentiallyfavorablesystemicandintratumoralimmuneeffectsinearlystagebreastcanceresbcpatients
AT hudisclifforda preoperativeimmunotherapywithtumorcryoablationcryoplusipilimumabipiinducespotentiallyfavorablesystemicandintratumoralimmuneeffectsinearlystagebreastcanceresbcpatients
AT wolchokjeddd preoperativeimmunotherapywithtumorcryoablationcryoplusipilimumabipiinducespotentiallyfavorablesystemicandintratumoralimmuneeffectsinearlystagebreastcanceresbcpatients
AT nortonlarry preoperativeimmunotherapywithtumorcryoablationcryoplusipilimumabipiinducespotentiallyfavorablesystemicandintratumoralimmuneeffectsinearlystagebreastcanceresbcpatients
AT mcarthurheatherl preoperativeimmunotherapywithtumorcryoablationcryoplusipilimumabipiinducespotentiallyfavorablesystemicandintratumoralimmuneeffectsinearlystagebreastcanceresbcpatients